glp 1 action mechanism of of GLP-1 [25] GLP-1 Receptor Agonists Explained for

Our systematic review found that GLP-1 RAs (such as exenatide, liraglutide, semaglutide, and the dual agonist tirzepatide) may significantly improve multiple facets of IIH: headaches, visual function, and induce substantial weight loss

Serious Risks While rare, there are potential serious risks associated with GLP-1 medications: Pancreatitis: Inflammation of the pancreas, which requires immediate medical attention

doi: 10.1042/cs20160935 98

The most common reasons include: Gastrointestinal side effects such as nausea, vomiting and diarrhea which are the single most frequently documented reason for stopping in large health system datasets High out of pocket cost and lack of insurance coverage particularly in individuals without diabetes Medication unavailability or pharmacy supply shortages which peaked in 2023early 2024 Perceived completion of therapy once target weight is reached or weight loss plateaus Concerns about long term safety or treatment burden of injections Many cohorts show substantial discontinuation by 3 months, with further losses by 6-9 months

[DOI] [PubMed] [Google Scholar] [141].Kim DH, Kim M, Kwon HJ

A cosa serve l'Acetil-L Carnitina